Transcatheter Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves

Transcatheter Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Valves

Below is a comprehensive review of performing transcatheter valve-in-valve implantation for a failed surgical bioprosthetic valves (open access).

Gurvitch et aal. 2011 JACC

Abstract

When bioprosthetic cardiac valves fail, reoperative valve replacement carries a higher risk of morbidity and mortality compared with initial valve replacement. Transcatheter heart valve implantation may be a viable alterna- tive to surgical aortic valve replacement for high-risk patients with native aortic stenosis, and valve-in-valve (V- in-V) implantation has been successfully performed for failed surgical bioprostheses in the aortic, mitral, pulmonic, and tricuspid positions. Despite some core similarities to transcatheter therapy of native valve disease, V-in-V therapy poses unique clinical and anatomic challenges. In this paper, we review the challenges, selection criteria, techniques, and outcomes of V-in-V implantation. (J Am Coll Cardiol 2011;58:2196–209)

About The Author

Structural Heart Disease Australia

Structural Heart Disease Australia is an incorporated association focused on education in valvular and structural cardiac diseases. It was started by group of echocardiographers, anaesthetists, clinical and interventional cardiologists, and cardiothoracic surgeons to provide a useful learning resource for medical professionals.

SHDA is supported by

Recent Tweets

Subscribe

Upcoming Meetings

july

28julAll DaySHDA Aortic Valve Symposium 2018SHDA AVS 2018

august

02augAll Day05Cardiac Society of Australia & New Zealand (CSANZ) 66th Annual Scientific MeetingCSANZ 2018

03augAll Day05Australia & New Zealand Endovascular Therapies (ANZET) Meeting 2018ANZET 2018

25augAll Day29European Society of Cardiology (ESC) Congress 2018ESC 2018

X